MedPath

The effect of Bupivacaine and Ropivacaine on labor Pai

Phase 2
Conditions
Epidural analgesia with two drugs, Bupivacaine and Rupivacaine.
Registration Number
IRCT20180903040936N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
112
Inclusion Criteria

Mothers with one fetus
Pregnant mothers who are candidates for vaginal delivery (Physiological delivery)
Nullipar pregnant mothers are candidates for vaginal delivery
Pregnant women referring to Taleghani Hospital with informed consent to participate in the study.
Mothers with ASA grade one and two
Pregnant mothers between the weeks 37-42 Who are perfectly pregnant
Pregnant mothers who are candidates for vaginal delivery, who are satisfied with epidertal analgesia

Exclusion Criteria

Patients in the epidural group who undergo epidural block failure after an epidural analgesia.
Pregnant mothers who are candidates for cesarean section for emergency reasons (such as placental abruption, umbilical cord prolapse, etc.).

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath